发明名称 Platelet aggregation inhibitors
摘要 The isolated and purified PAI from several active snake venoms is described and characterized. In addition, PAIs lacking the Arg-Gly-Asp (RGD) adhesion sequence but containing K* -(G/Sar)-D wherein K* is a modified lysyl residue of the formulaR12 N(CH 2)4CHNHCO-wherein each R1 is independently H, alkyl(1-6C) or at most one R1 is R2-C=NR3 wherein R2 is H, alkyl(1-6C), phenyl or benzyl, or is NR4 2 in which each R4 is independently H or alkyl(1-6C) and R3 is H, alkyl(1-6C), phenyl or benzyl, or R2-C=NR3 is a radical selected from the group consisting of: where m is an integer of 2-3, and each R5 is independently H or alkyl(1-6C); and wherein one or two (CH2) may be replaced by O or S provided said O or S is not adjacent to another heteroatom are prepared and shown to specifically inhibit the binding of fibrinogen or von Willebrand Factor to GP IIb-IIIa.
申请公布号 US5968902(A) 申请公布日期 1999.10.19
申请号 US19950482263 申请日期 1995.06.07
申请人 COR THERAPEUTICS, INC. 发明人 SCARBOROUGH, ROBERT M.;WOLF, DAVID LAWRENCE;CHARO, ISRAEL F.
分类号 A61K38/00;A61K38/12;A61K38/17;A61K38/57;C07K14/46;C07K14/75;C07K14/755;C07K14/78;(IPC1-7):A61K38/00;C07K5/00;C07K7/00 主分类号 A61K38/00
代理机构 代理人
主权项
地址